21-34859476-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM5_SupportingPP3PM2_SupportingPS4_ModeratePP1_StrongPM1
This summary comes from the ClinGen Evidence Repository: The NM_001754.4:c.611G>A (p.Arg204Gln) variant affects one of the 13 hotspot residues established by the MM-VCEP for RUNX1 (PM1). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). This missense variant has a REVEL score >0.75 (0.958) (PP3). This variant has been reported in three probands meeting at least one of the RUNX1-phenotypic criteria (PS4_ moderate; PMID:19357396, PMID:27112265, PMID:26316320, PMID:27479822). This variant was found to co-segregate with disease in multiple affected family members, with seven meioses observed across 3 families (PP1_strong; PMID:19357396, PMID:27112265, PMID:26316320, PMID:27479822). This variant is a missense change at the same residue (p.R204) where a different missense change has been previously established as a likely pathogenic variant (ClinVar ID 2177591) based on MM-VCEP rules for RUNX1 and RNA data or agreement in splicing predictors (SSF and MES) show no splicing effects (PM5_Supporting). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PP1_strong, PM1, PM2, PS4_moderate, PP3, PM5_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA410207938/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458178Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 725764
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74294
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
- -
Observed in the germline of individuals with thrombocytopenia, myelodysplastic syndrome, acute myeloid leukemia, and/or acute lymphocytic leukemia in published literature (PMID: 27112265, 31130284, 32935436, 35739278); Published functional studies demonstrate a damaging effect: reduced DNA binding and transactivation (PMID: 10068652, 12393679); Not observed at significant frequency in large population cohorts (gnomAD); Also known as p.R177Q; This variant is associated with the following publications: (PMID: 32782381, 31291480, 34166225, 32581362, 32935436, 31130284, 27112265, 19357396, 32208489, 26316320, 33778416, 34407276, 12393679, 27479822, 35739278, 36819173, 34958450, 37680325, Nitschke2023[article], 10068652) -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Pathogenic:1
The NM_001754.4:c.611G>A (p.Arg204Gln) variant affects one of the 13 hotspot residues established by the MM-VCEP for RUNX1 (PM1). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). This missense variant has a REVEL score >0.75 (0.958) (PP3). This variant has been reported in three probands meeting at least one of the RUNX1-phenotypic criteria (PS4_ moderate; PMID: 19357396, PMID: 27112265, PMID: 26316320, PMID: 27479822). This variant was found to co-segregate with disease in multiple affected family members, with seven meioses observed across 3 families (PP1_strong; PMID: 19357396, PMID: 27112265, PMID: 26316320, PMID: 27479822). This variant is a missense change at the same residue (p.R204) where a different missense change has been previously established as a likely pathogenic variant (ClinVar ID 2177591) based on MM-VCEP rules for RUNX1 and RNA data or agreement in splicing predictors (SSF and MES) show no splicing effects (PM5_Supporting). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PP1_strong, PM1, PM2, PS4_moderate, PP3, PM5_supporting. -
Thrombocytopenia;C1458140:Abnormal bleeding Pathogenic:1
- -
Thrombocytopenia Pathogenic:1
- -
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 204 of the RUNX1 protein (p.Arg204Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with thrombocytopenia or acute myeloid leukemia (PMID: 19357396, 27112265, 32208489, 32581362, 32935436). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg177Gln. ClinVar contains an entry for this variant (Variation ID: 561253). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects RUNX1 function (PMID: 10068652, 11830488, 12002768, 22012064). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at